Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIPEGFILGRASTIM vs LISINOPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LIPEGFILGRASTIM vs LISINOPRIL: Safety Overview

Metric LIPEGFILGRASTIM LISINOPRIL
Total FAERS Reports 425 36,869
Deaths Reported 41 4,382
Death Rate 9.6% 11.9%
Hospitalizations 248 13,362
Average Patient Age 56.4 yrs 61.5 yrs
% Female Patients 50.0% 51.9%
FDA Approval Date N/A Apr 19, 2007
Manufacturer N/A Legacy Pharmaceutical Packaging, LLC
Route N/A ORAL
Marketing Status N/A Discontinued